RICC A/S: Financial statements 2023
CVR: 20690003
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
RICC A/S (CVR 20690003) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 76,967,000 and a net result of DKK -2,757,000 compared with DKK 9,339,000 the year before. That is a decrease of 63.4% compared with the year before. Equity in the 2023 report amounted to DKK 1,699,000. The solvency ratio was 6.8%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 76,967,000
- Profit/Loss
- DKK -2,757,000
- Equity
- DKK 1,699,000
- Total Assets
- DKK 24,930,000
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 77 mio. | -2.8 mio. | 1.7 mio. | 42 |
| 2022 | - | 210.2 mio. | 9.3 mio. | 4.5 mio. | 57 |
| 2021 | - | 133.7 mio. | 4.5 mio. | -4.9 mio. | 70 |
| 2020 | - | 274.3 mio. | -155.8 mio. | -6 mio. | 63 |
| 2019 | - | 141.4 mio. | 45.9 mio. | 209.8 mio. | 65 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
RICC A/S has published its annual report for 2022. Gross profit came to DKK 210,237,000, and the net result was DKK 9,339,000.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.